Using blood routine data to predict cervical cancer
Cervical cancer is the most common gynecological malignancy. The high incidence age of carcinoma in situ is 30-35 years old, and the age of invasive carcinoma is 45-55 years old. In recent years, the incidence of cancer has been younger. The widespread application of cervical cytology screening in recent decades has enabled early detection and treatment of cervical cancer and precancerous lesions, and the incidence and mortality of cervical cancer have decreased significantly. We have built an accurate cervical cancer prediction model through artificial intelligence. Users only need to submit blood routine data to judge whether they have cervical cancer.